News Search Results

Displaying Results 51-75 of 1930 "COVID-19"

Feb 26, 2026, 08:00 ET Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

1/2 data from their influenza-COVID-19 combination programs and their belief that these data support the high probability of demonstrating non-inferiority in Phase 3 trials that would compare the new vaccine against the widely used regimen where both the flu and COVID-19 vaccines are co-administered.Sanofi

More news about: Novavax, Inc.


Feb 26, 2026, 07:30 ET Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet's Disease

candidate, as well as our vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax™, our vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2). The development of our vaccine programs incorporates the use of our proprietary heat stabilization platform technology, known

More news about: SOLIGENIX, INC.


Feb 26, 2026, 06:30 ET United Parks & Resorts Inc. Reports Fourth Quarter and Fiscal 2025 Results

%COVID-19 related incremental costs (h)

More news about: United Parks and Resorts Inc.


Feb 25, 2026, 19:04 ET Genomma Lab Internacional Announces Results for the Fourth Quarter and Full Year 2025

forward-looking statements, which speak only as of their dates. Risks and uncertainties include, but are not limited to: risks related to the impact of the COVID19 global pandemic, such as the scope and duration of the outbreak, government actions and restrictive measures implemented in response, material delays,

More news about: Genomma Lab Internacional, S.A.B. de C.V.


Feb 25, 2026, 18:16 ET Differing immune responses in infants may explain increased severity of RSV over SARS-CoV-2

infants hospitalized with respiratory syncytial virus (RSV) often become much sicker compared to those infected with SARS-CoV-2, the virus that causes COVID-19. In a study published today in Science Translational Medicine, scientists from St. Jude Children's Research Hospital and The Jackson Laboratory

More news about: St. Jude Children's Research Hospital


Feb 25, 2026, 15:54 ET AMFA WINS REPRESENTATION ELECTION AT ALASKA AIRLINES AND HAWAIIAN AIRLINES

Airlines, Horizon Air, Southwest Airlines, WestJest Airlines, and Calm Air, with proven success protecting jobs during industry disruptions, including the COVID-19 pandemic and airline mergers."This election win represents confidence of maintenance professionals in AMFA's ability to deliver meaningful

More news about: Aircraft Mechanics Fraternal Association


Feb 25, 2026, 09:00 ET 揭示腸道細菌與癌症治療關聯性的研究榮膺 Bial 生物醫學獎,獲頒 35 萬歐元獎金

項提名,涵蓋癌症、傳染病及神經退化性疾病等領域。 歷屆獲得表彰的傑出研究成果,後來都贏得了蜚聲國際的科學獎項。 值得注意的是,兩位曾於 2021 年獲得「BIAL 生物醫學獎」的科學家 Katalin Karikó 與 Drew Weissman,榮獲了 2023 年諾貝爾生理學或醫學獎以表彰他們的發現,讓研發能有效防治 COVID-19 的 mRNA 疫苗成為現實。

More news about: Bial Foundation


Feb 25, 2026, 09:00 ET Entdeckung zum Zusammenhang zwischen Darmbakterien und Krebstherapie gewinnt den Bial Award in Biomedicine und erhält 350.000 Euro Preisgeld

2023 den Nobelpreis für Physiologie oder Medizin für ihre Entdeckungen, die die Entwicklung wirksamer mRNA-basierter Impfstoffe zur Prävention von COVID-19 ermöglichten.Foto - https://mma.prnewswire.com/media/2919779/Bial_Award.jpgLogo

More news about: Bial Foundation


Feb 25, 2026, 09:00 ET 腸内細菌とがん治療の関連を解明した発見が「BIAL生物医学賞(BIAL Award in Biomedicine)」を受賞、35万ユーロを獲得

、後に権威ある国際的な科学賞を受賞しています。特筆すべきことに、2021年にBIAL生物医学賞(BIAL Award in Biomedicine)を受賞した2人の科学者、Katalin Karikó氏とDrew Weissman氏は、COVID‑19を予防する効果的なmRNAワクチンの開発を可能にした発見により、2023年のノーベル生理学・医学賞を受賞しました。写真:https://mma.prnewswire.com/media/2919779/Bial_Award.jpgロゴ:

More news about: Bial Foundation


Feb 25, 2026, 09:00 ET Descoberta ligando bactérias intestinais ao tratamento do câncer vence o Prêmio Bial em Biomedicina e recebe € 350.000

Fisiologia ou Medicina de 2023 por suas descobertas que possibilitaram o desenvolvimento de vacinas eficazes baseadas em mRNA para prevenir a COVID-19.Foto - https://mma.prnewswire.com/media/2919779/Bial_Award.jpgLogotipo

More news about: Bial Foundation


Feb 25, 2026, 09:00 ET El descubrimiento que vincula las bacterias intestinales con el tratamiento del cáncer gana el Premio Bial

Nobel de Fisiología o Medicina 2023 por sus descubrimientos que permitieron el desarrollo de vacunas eficaces basadas en ARNm para prevenir la COVID-19.Foto - https://mma.prnewswire.com/media/2919779/Bial_Award.jpgLogo

More news about: Bial Foundation


Feb 25, 2026, 09:00 ET El descubrimiento que vincula las bacterias intestinales con el tratamiento contra el cáncer gana el premio Bial en Biomedicina y recibe un galardón de 350.000 euros

Fisiología o Medicina 2023 por sus descubrimientos que permitieron el desarrollo de vacunas efectivas basadas en ARNm para prevenir la enfermedad de COVID-19.Foto - https://mma.prnewswire.com/media/2919779/Bial_Award.jpgLogotipo

More news about: Bial Foundation


Feb 25, 2026, 09:00 ET Une découverte liant les bactéries intestinales au traitement du cancer remporte le prix Bial Award in Biomedicine et se voit attribuer une somme de 350 000 EUR

prix Nobel de physiologie ou médecine en 2023 pour leurs découvertes ayant permis le développement de vaccins à base d'ARNm efficaces contre la COVID-19.Photo - https://mma.prnewswire.com/media/2919779/Bial_Award.jpgLogo

More news about: Bial Foundation


Feb 25, 2026, 08:10 ET VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution

doi: 10.1186/s13613-023-01204-y.Morimont, L., et al. (2022). NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study. Biomolecules, 12(8), 1038. doi: 10.3390/biom12081038Bouazzi

More news about: VolitionRx Limited


Feb 25, 2026, 08:00 ET Contango Ore Intersects 60.22 g/t Gold over 5.92 meters, including 294.77 g/t Gold over 1.16 meters from Underground Drilling Program at the Lucky Shot Project, Alaska, USA

acquisitions; inability of our management team to execute its plans to meet its goals; the extent of disruptions caused by an outbreak of disease, such as the COVID-19 pandemic; and the possibility that government policies may change, political developments may occur or governmental approvals may be delayed or withheld,

More news about: Contango Ore


Feb 25, 2026, 07:30 ET BTQ Technologies Announces New Quantum Hardware Commercialization Hub in New York City and Key Engineering Hires to Accelerate QCIM

conditions in the financial markets; changes in laws (including regulations respecting blockchains); risks related to the direct and indirect impact of COVID-19 including, but not limited to, its impact on general economic conditions, the ability to obtain financing as required, and causing potential delays

More news about: BTQ Technologies Corp.


Feb 25, 2026, 07:00 ET Joint U.S. Commercialization of RedHill's Talicia® Commences

countermeasures including radiation and chemical exposure indications such as GI-Acute Radiation Syndrome (GI-ARS), a Phase 2/3 program for hospitalized COVID-19, and a Phase 2 study in prostate cancer in combination with darolutamide; (ii) RHB-204, a next-generation optimized formulation of RHB-104,

More news about: RedHill Biopharma Ltd.


Feb 24, 2026, 13:00 ET Walter Koroshetz Joins the Dana Foundation as Senior Advisor

in a number of cross-NIH and NINDS programs including co-leading the NIH's BRAIN Initiative; the NIH RECOVER Initiative on Post Acute Sequelae of COVID-19; the NIH Blueprint for Neuroscience; the TBI Center between the NIH and the Uniformed Health Services University; the Helping to End Addiction Long

More news about: Dana Foundation


Feb 24, 2026, 10:20 ET Clinical Microbiology Market on Track to Reach $9.7 Billion by 2033: Allied Market Research

prevalence of respiratory infections such as influenza, pneumonia, and tuberculosis, along with the growing threat of emerging viral infections like COVID-19. Bloodstream infections, which are often life-threatening, also contribute significantly to market growth, with increasing demand for rapid blood culture

More news about: Allied Market Research


Feb 24, 2026, 09:05 ET Investing.com Publishes In-Depth VantagePoint A.I. Review by Trading Legend Ralph Vince

VantagePoint has demonstrated consistent performance through every major market environment of the past 35 years; from the 2008 financial crisis to the COVID-19 disruption to today's geopolitical uncertainty.Traders interested in learning how A.I.-powered forecasting can transform their trading are

More news about: VantagePoint Software


Feb 24, 2026, 09:05 ET Chalik & Chalik Injury and Accident Lawyers Champions Stomach Cancer Awareness in South Florida

Plantation, and Miami to cruise ship injuries governed by federal maritime law. Debi Chalik made history as the first attorney to sue a cruise line for Covid-19 passenger exposure, securing settlements for over one hundred clients in under a year. The same tenacity the Chaliks bring to their clients they bring

More news about: Chalik & Chalik Injury & Accident Lawyers


Feb 24, 2026, 09:00 ET Sanyou Biopharmaceuticals Announces New Strategic Investor; Liferiver Biotech Increases Its Stake, and Gree Group's Yanghe Investment Joins as a Strategic Shareholder

and growth trajectory. Since their initial partnership, the two companies have achieved deep collaboration across innovative biologics automation, COVID-19 therapeutic antibody development, and other key areas. With the increased shareholding, both parties plan to intensify their joint efforts in novel

More news about: Sanyou Bio


Feb 24, 2026, 09:00 ET THE AUDACIOUS PROJECT NAMES NEW GRANTEE COHORT CATALYZING GLOBAL CHANGE

support from Audacious, projects have driven medical breakthroughs — developing the world's first computer-generated protein medicine, revolutionizing COVID-19 response systems and repurposing medicines to cure rare diseases. From creating the first whale language model to transforming how we track methane

More news about: TED Conferences


Feb 24, 2026, 08:36 ET UEI Stone Mountain Graduate Overcomes Adversity to Spark Career

Power, traveling to document power grid conditions near nuclear power plants. Seeking long-term stability and professional certifications following the COVID-19 pandemic, she enrolled in UEI's Electrician Technician program. Staples excelled academically, maintaining a nearly perfect GPA and perfect attendance

More news about: United Education Institute


Feb 24, 2026, 07:30 ET Soligenix to Present at BIO Investment & Growth Summit

candidate, as well as our vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax™, our vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2). The development of our vaccine programs incorporates the use of our proprietary heat stabilization platform technology, known

More news about: SOLIGENIX, INC.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.